HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

311.696

+2.4740.80%

Number of Gainers:31

Number of Losers:18

Number of Flat:10

PE:- -

High:312.881

Open:309.322

Low:306.839

Close:309.222

Volume:87.02M

Turnover:2.87B

Market Cap:736.91B

Float Cap:653.73B

Loading ...

Chaoju Eye Care Spends HK$168,900 to Repurchase 70,000 Shares on September 29

ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29

UK's Billington Holdings H1 Profit Jumps 70% on Data Centre Demand

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

China's Hutchmed Climbs as AstraZeneca Applies for US Cancer Drug Approval

MIXUE GROUP Announces Grant of 12.0233 Million Awards

CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B

HUTCHMED Announces U.S. New Drug Application Submission for ORPATHYS® Combined with TAGRISSO® in MET-Driven EGFR-Mutant Lung Cancer

CARsgen Says First Patient Dosed in China Phase I Registrational Trial of Ct1190b CAR-T for R/R LBCL

Hutchmed Announces Submission of US Nda for Orpathys® Plus Tagrisso® in Met-Driven Egfr-Mutated Lung Cancer

THOMSON REUTERS

Asian Penny Stocks To Watch In September 2026

Simply Wall St.

Kindstar Global (09960) Spends HK$24,300 to Buy Back 26,500 Shares on September 28

Baidu Group-W Repurchases 583,700 Shares for HK$49.996 Million on September 28

Li Auto Steps Up Hong Kong Share Buybacks With HK$58 Million Repurchase

Hong Kong Inbound and Outbound Travel Demand Both Rise During Golden Week, Visitor Sources Diversify

Hutchmed Climbs After on Initiating HMPL-A830 Global Trial in Solid Tumors

ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25

HUTCHMED Launches Global Phase I Study of KRAS-EGFR Antibody-Targeted Therapy HMPL-A830 for Solid Tumors

Hutchmed Initiates Global Trial of Kras-Egfr-Antibody Conjugate Therapy Hmpl-A830 in Patients with Solid Tumors

THOMSON REUTERS

HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK1587/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":311.6957,"timestamp":1790755705764,"preClose":309.22168,"halted":0,"volume":87019335,"delay":0,"changeRate":0.008001,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed National Day","change":2.47403,"latestTime":"09-30 16:00:00","open":309.32233,"high":312.8808,"low":306.83902,"amount":2874126653,"amplitude":0.019539,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"pbRate":1.305798,"peRate":17.968428,"turnoverRate":0.001648,"increases":30,"decrements":17,"flats":11,"marketCap":736907117176,"floatMarketCap":653733485384},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":312.8808,"amplitude":0.019539,"preClose":309.22168,"low":306.83902,"pbRate":"1.305798","latestPrice":311.6957,"volume":87019335,"delay":0,"open":309.32233,"prevYearClose":478.5753,"prevWeekClose":311.9,"prevMonthClose":311.696,"prevQuarterClose":311.696,"fiveDayClose":320.654,"twentyDayClose":333.444,"sixtyDayClose":344.572,"secType":"PLATE","market":"HK","turnoverRate":0.001648,"peRate":17.968428,"marketCap":736907117176,"floatMarketCap":653733485384,"timestamp":1790755705764,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":31,"down":18,"flat":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1195756961","title":"Chaoju Eye Care Spends HK$168,900 to Repurchase 70,000 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1195756961","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195756961?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:44","pubTimestamp":1790675063,"startTime":"0","endTime":"0","summary":"Chaoju Eye Care (02219) announced that on September 29, 2026, the company spent HK$168,900 to repurchase 70,000 shares.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02219","BK1209","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111891998","title":"ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1111891998","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111891998?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:58","pubTimestamp":1790672320,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 29, 2026, the company spent HK$1.1383 million to repurchase 53,000 shares, with a repurchase price ranging from HK$21.36 to HK$21.54 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1583","02190","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671295629","title":"UK's Billington Holdings H1 Profit Jumps 70% on Data Centre Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2671295629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671295629?lang=en_us&edition=fundamental","pubTime":"2026-09-29 14:10","pubTimestamp":1790662221,"startTime":"0","endTime":"0","summary":"UK's Billington Holdings H1 profit jumps 70% on data centre demandOverviewUK structural steel specialist's H1 revenue rose 29%, driven by higher steel content in projectsProfit before tax for H1 up 70","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL1N45L05K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1078025761.USD","LU1323610961.USD","AZN.UK","LU0857590862.USD","LU1989772840.SGD","LU2468319806.SGD","LU2539964713.USD","LU0949170772.SGD","LU1291159041.SGD","00013","IE00BKPKM643.USD","LU0972486137.USD","LU0557290698.USD","LU0997586432.USD","LU2357627491.SGD","LU1261432733.SGD","LU0784384876.USD","LU2089284900.SGD","LU3187612489.SGD","LU0128525929.USD","LU1301847155.USD","LU0757432116.USD","BILN.UK","LU0889566641.SGD","LU1057294990.SGD","LU2293690082.USD","LU1989771016.USD","LU0823416689.USD","LU0047473722.EUR","LU1104425308.USD","03165","LU1481600234.SGD","LU0889565080.SGD","LU0114720955.EUR","LU1880407215.USD","LU0128525689.USD","LU0827474353.SGD","LU2293690249.USD","BK1587","LU1153584641.USD","LU0997586515.USD","LU0052756011.USD","LU2114397693.USD","LU0784383803.USD","LU0432979614.USD","LU0859254822.USD","SG9999013999.USD","LU0310799852.SGD","SG9999001176.SGD","LU1487256676.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1587","BK1161","02162","IBBQ","BK1583","MEDX","BK1574","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671628132","title":"China's Hutchmed Climbs as AstraZeneca Applies for US Cancer Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2671628132","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671628132?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:22","pubTimestamp":1790648560,"startTime":"0","endTime":"0","summary":"BUZZ-China's HUTCHMED climbs as AstraZeneca applies for US cancer drug approval** Shares of HUTCHMED (China)0013.HKclimb 4.1% to HK$23.1, their highest level since September 4** Stock on track for its","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL1N45L02E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889566641.SGD","LU0957799991.USD","03165","LU0047473722.EUR","LU1267930490.SGD","LU1291159041.SGD","LU1084165304.USD","LU2023251221.USD","LU0889565080.SGD","LU1023059063.AUD","LU0964806797.USD","LU1170363599.USD","LU1863844749.USD","LU0203345920.USD","LU1078025761.USD","LU0887340254.USD","LU0114720955.EUR","LU0997586515.USD","LU0920783379.SGD","LU0390134368.USD","SG9999013999.USD","LU0859254822.USD","00013","LU0345777659.USD","LU2091194634.USD","LU0128525689.USD","BK1587","LU2237443465.HKD","LU0972486137.USD","LU1153585028.USD","LU2237443622.USD","LU1003076772.USD","LU0047473722.SGD","LU1989772923.USD","LU0545039389.USD","LU1487256676.USD","LU1061106388.HKD","LU2237443382.USD","LU0784384876.USD","LU1003077747.HKD","LU2089283258.USD","LU2433249047.HKD","LU2324357040.USD","LU1267930813.SGD","LU2108987350.USD","LU0211326755.USD","AZN.UK","LU0029864427.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188948399","title":"MIXUE GROUP Announces Grant of 12.0233 Million Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=1188948399","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188948399?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:50","pubTimestamp":1790643032,"startTime":"0","endTime":"0","summary":"MIXUE GROUP (02097) has issued an announcement that on September 28, 2026, the company granted a total of 12.0233 million awards to 1,234 grantees under its H-share award scheme.The grant of awards...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02097","BK1616","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146102396","title":"CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B","url":"https://stock-news.laohu8.com/highlight/detail?id=1146102396","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146102396?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:10","pubTimestamp":1790640613,"startTime":"0","endTime":"0","summary":"According to an announcement by CARSGEN-B (02171), CT1190B, a universal CAR-T cell product targeting CD19/CD20, has completed the first patient infusion in its Phase I registration clinical trial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","MDTX","BMED","BK1161","BK1574","BK1587","BK1585","02171","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124332544","title":"HUTCHMED Announces U.S. New Drug Application Submission for ORPATHYS® Combined with TAGRISSO® in MET-Driven EGFR-Mutant Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1124332544","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124332544?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:08","pubTimestamp":1790640493,"startTime":"0","endTime":"0","summary":"HUTCHMED announced that AstraZeneca has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for the combination therapy of ORPATHYS® (savolitinib) and TAGRISSO®...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1191","00013","IPOS","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671707265","title":"CARsgen Says First Patient Dosed in China Phase I Registrational Trial of Ct1190b CAR-T for R/R LBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2671707265","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671707265?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:00","pubTimestamp":1790640058,"startTime":"0","endTime":"0","summary":"CARsgen says first patient dosed in China Phase I registrational trial of CT1190B CAR-T for R/R LBCLCARsgen dosed the first patient in China in a registrational Phase I trial of CT1190B for relapsed o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4XW7vr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1585","BK1574","02171","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671265724","title":"Hutchmed Announces Submission of US Nda for Orpathys® Plus Tagrisso® in Met-Driven Egfr-Mutated Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671265724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671265724?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:00","pubTimestamp":1790640000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA6M4WX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1588","00013","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260600","title":"Asian Penny Stocks To Watch In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260600","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260600?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:02","pubTimestamp":1790632923,"startTime":"0","endTime":"0","summary":"As Asia's markets navigate a complex landscape marked by inflation concerns and fluctuating interest rates, investors are keenly watching for opportunities that can weather these challenges. Penny stocks, though often seen as relics of the past, continue to offer intriguing prospects for those willing to explore lesser-known companies with potential for growth. These smaller or newer firms can provide a unique combination of value and stability when backed by strong financials, making them an...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/8081392-card/1790632923198","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/8081392-card/1790632923198"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/food-beverage-tobacco/sgx-f03/food-empire-holdings-shares/news/asian-penny-stocks-to-watch-in-september-2026-7","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/food-beverage-tobacco/sgx-f03/food-empire-holdings-shares/news/asian-penny-stocks-to-watch-in-september-2026-7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1587","06608","Y92.SI","BK6509","LU0348798264.USD","SG9999002414.USD","BK6080","LU0048621477.USD","LU0205439572.USD","BK1583","LU0877626530.USD","LU1119993845.HKD","BK6523","BK1575","SG9999002950.SGD","BK1109","SG9999002406.SGD","BK6114","LU1046422090.SGD","BK1131","F03.SI","LU0049112450.USD","LU1235295612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184265139","title":"Kindstar Global (09960) Spends HK$24,300 to Buy Back 26,500 Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1184265139","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184265139?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:24","pubTimestamp":1790594653,"startTime":"0","endTime":"0","summary":"Kindstar Global (09960) has announced that on September 28, 2026, the company repurchased 26,500 shares for HK$24,300, at a repurchase price of HK$0.91 to HK$0.95 per share.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09960","BK1219","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121785358","title":"Baidu Group-W Repurchases 583,700 Shares for HK$49.996 Million on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1121785358","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121785358?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:12","pubTimestamp":1790593976,"startTime":"0","endTime":"0","summary":"On September 28, 2026, Baidu Group-W (09888) announced that it repurchased 583,700 shares for HK$49.996 million.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201885.HKD","LU0164865239.USD","LU1481107354.HKD","HK0000306701.USD","LU0228367735.SGD","LU0197773160.USD","LU1188198961.HKD","LU0630378429.USD","LU0543330566.HKD","IE0034224299.USD","LU0164880469.USD","HK0000320264.USD","LU2778985437.USD","BK1575","LU0417516902.SGD","LU1048588211.SGD","SG9999002828.SGD","LU1048596156.SGD","LU0348825331.USD","BIDU","LU0762541174.USD","TCHI","LU0531971595.HKD","HK0000320223.HKD","LU2476274308.USD","LU0871576103.HKD","LU0039217434.USD","LU0197773673.USD","LU0823426308.USD","LU0072462343.USD","LU0307460666.USD","LU0348735423.USD","LU0315179316.USD","LU0630378692.HKD","LU0417516738.SGD","LU0588546209.SGD","LU0326950275.SGD","LU0708995583.HKD","LU0229945570.USD","LU1831875114.USD","LU0052750758.USD","LU0821914370.USD","LU0244354667.USD","LU1023057109.AUD","SG9999014674.SGD","BK1615","LU0819121731.USD","BK1095","LU0831093199.SGD","LU0287142896.SGD","09888","LU0051755006.USD","LU0762542818.HKD","IE00B3M56506.USD","LU0320764599.SGD","LU0856984785.SGD","LU0456827905.SGD","LU1328615791.USD","LU1115378108.SGD","LU0173614495.USD","BK1609","LU0640798160.USD","BK1588","89888","LU1206782309.USD","LU2039709279.SGD","SG9999002463.SGD","LU0359202008.SGD","LU0043850808.USD","LU0163747925.USD","LU0149721374.USD","LU0359201612.USD","LU0823426480.USD","HK0000306685.HKD","BK1587","LU0463099449.HKD","LU0762540952.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239386","title":"Li Auto Steps Up Hong Kong Share Buybacks With HK$58 Million Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239386","media":"TIPRANKS","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239386?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:28","pubTimestamp":1790591287,"startTime":"0","endTime":"0","summary":"Li Auto ( ($LI) ) just unveiled an update. On September 21, 2026, Li Auto repurchased 1,272,800 Class A WVR ordinary shares on the Hong Kong Stock ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/li-auto-steps-up-hong-kong-share-buybacks-with-hk58-million-repurchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/li-auto-steps-up-hong-kong-share-buybacks-with-hk58-million-repurchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK1539","BK1588","BK1575","LI","LU1794554557.SGD","BK1587","02015","LU1720050803.USD","BK1119","IDRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182300232","title":"Hong Kong Inbound and Outbound Travel Demand Both Rise During Golden Week, Visitor Sources Diversify","url":"https://stock-news.laohu8.com/highlight/detail?id=1182300232","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182300232?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:02","pubTimestamp":1790575335,"startTime":"0","endTime":"0","summary":"As the National Day Golden Week approaches, the latest data from Trip.com shows that both inbound and outbound travel demand for Hong Kong has recorded growth.During the Golden Week, overall bookings...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0164880469.USD","LU2424517915.HKD","IE00B5MMRT66.SGD","SG9999000418.SGD","LU0329678337.USD","BK4526","LU0348827113.USD","LU0039217434.USD","LU0431992006.USD","LU0326950275.SGD","LU2399975544.HKD","LU1719994722.HKD","LU0054237671.USD","BK4588","LU2476274308.USD","IE00BPRC5H50.USD","LU0463099449.HKD","HK0000320223.HKD","LU1282649067.USD","LU2778985437.USD","LU0384037296.USD","LU0261950470.USD","LU1102505929.USD","LU0737861699.HKD","LU0823426480.USD","LU2242644610.SGD","LU1102505762.USD","SG9999001093.SGD","LU2153591404.USD","LU0737861772.HKD","LU2023250504.SGD","LU0348735423.USD","LU0509642566.USD","LU0634319403.HKD","LU1868837722.USD","BK4585","LU0315179316.USD","IE00B0JY6N72.USD","LU0143863784.USD","LU0456846285.SGD","IE00B8HQ1Z84.USD","LU1224709979.USD","IE0008368742.USD","LU2449936058.SGD","BK4534","LU0251143458.SGD","BK1587","LU0181495838.USD","IE0003851619.USD","LU1794554557.SGD","LU0011963245.USD","LU2039709279.SGD","LU0049853897.USD","LU0531971595.HKD","LU0871576103.HKD","LU0516422440.USD","LU0320764599.SGD","LU0828238088.HKD","BK4531","LU1303224171.USD","BEDZ","LU0231483743.USD","LU0173614495.USD","LU0979878070.USD","LU0455707207.USD","LU0605514214.HKD","LU0823397285.USD","LU1813983027.USD","LU0307460666.USD","LU1328277881.USD","LU0594300419.USD","LU1282649810.SGD","LU0051755006.USD","LU3063872942.SGD","LU1481107354.HKD","SG9999002463.SGD","HK0000320264.USD","LU1770034418.SGD","LU1328615791.USD","LU2152927971.USD","TCOM","LU0828237510.HKD","IE0008369823.USD","LU0228659784.USD","LU1868838027.USD","SG9999000475.SGD","LU0244354667.USD","LU0211977185.USD","LU1251922891.USD","LU0149721374.USD","LU0261950983.USD","LU1974910355.USD","LU0828237940.HKD","SG9999000459.SGD","LU1880383440.USD","LU1917777945.USD","LU0052750758.USD","LU0823426308.USD","LU1808992512.USD","IE00B3M56506.USD","LU0359201885.HKD","SG9999001903.USD","BK1588","LU0594300179.USD","LU1961090484.USD","BK4142","BK1615","LU1880383366.USD","LU0572944931.SGD","LU1868837565.USD","BK1164","LU1242518857.USD","LU0143863198.USD","HK0000306701.USD","LU0106252389.USD","LU0164865239.USD","LU0348825331.USD","LU0048575426.USD","LU2348773727.SGD","LU0287142896.SGD","LU2476274720.SGD","LU0488056044.USD","LU0210526637.USD","LU0359202008.SGD","IE00B031HY20.USD","LU0314109678.HKD","LU1023057109.AUD","09961","LU0516422952.EUR","LU1720050803.USD","LU0516423174.USD","SG9999002562.SGD","LU0048580855.USD","LU1188198961.HKD","SG9999011746.SGD","LU0540923850.HKD","LU0107464264.USD","LU0327786744.USD","LU0708995583.HKD","BK1604","LU0868486357.SGD","LU2106854487.HKD","LU0329678170.USD","LU0370786039.SGD","LU0359201612.USD","LU0650527681.SGD","LU0588546209.SGD","LU0417516902.SGD","LU1242518931.SGD","IE0003795394.USD","LU0516423091.SGD","LU0269904917.USD","LU0417516738.SGD","IE00B8L5B284.USD","LU0823397103.USD","LU0593848301.USD","HK0000306685.HKD","LU0456827905.SGD","LU0561508036.HKD","IE0034224299.USD","LU0502904849.HKD","LU1956131251.USD","LU0516422366.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283478","title":"Hutchmed Climbs After on Initiating HMPL-A830 Global Trial in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283478","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670283478?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:53","pubTimestamp":1790567594,"startTime":"0","endTime":"0","summary":"BUZZ-HUTCHMED climbs after on initiating HMPL-A830 global trial in solid tumors** Shares of HUTCHMED 0013.HKclimb 2.6% to HK$22.5, on course for the biggest one-day pct gain since September 21** Stock set to snap two straight sessions of fall** The pharmaceuticals manufacturer says it has initiated the Phase Ia part of aglobal clinical trial of HMPL-A830in patients with unresectable, advanced or metastatic solid tumors** HUTCHMED says its unit, on September 3, entered into an exclusive development and license agreement with a GSK plc unit, granting the GSK unit worldwide rights to develop and commercialize HMPL-A830 with HUTCHMED responsible for the global Phase  development program of HMPL-A830** YTD, Hong Kong stock up 7.5%, Hang Seng Biotech Index.HSBIOup 11.6%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL1N45K02M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0225284248.USD","LU2646069778.SGD","LU0575583348.USD","IE00BQJZX424.USD","LU0545562505.USD","LU0557290698.USD","LU1046248800.SGD","LU1015430645.USD","LU0211331839.USD","00013","SG9999013999.USD","LU0987226296.USD","SGXZ57979304.SGD","LU1098665638.USD","LU1983299246.USD","LU1481600234.SGD","LU0203345920.USD","LU1400636491.USD","LU1400636574.HKD","LU1228905540.USD","LU0971552830.HKD","BK1587","LU0321505439.SGD","LU0161305163.EUR","LU0971552673.USD","LU1228905037.USD","LU0203347892.USD","SG9999001176.SGD","LU0109981661.USD","LU1202635105.USD","LU0985481810.HKD","LU1645745479.HKD","IE0034235071.USD","BK5011","LU0289739699.SGD","LU0306807586.USD","LU0321505868.SGD","IE00B3T34201.USD","BK1588","LU0306806265.USD","LU2089984988.USD","LU1064927863.SGD","LU1670756490.USD","LU2468319806.SGD","LU1035777561.USD","LU1481599808.USD","LU1487256676.USD","IE00BWDBJ516.SGD","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196699729","title":"ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1196699729","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196699729?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:50","pubTimestamp":1790556615,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has released an announcement stating that on September 25, 2026, the company spent HK$1.1571 million to repurchase 54,000 shares.The announcement disclosed the share buyback details, with the company allocating HK$1.1571 million for the repurchase of 54,000 shares on that date.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","BK1587","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184876105","title":"HUTCHMED Launches Global Phase I Study of KRAS-EGFR Antibody-Targeted Therapy HMPL-A830 for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1184876105","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184876105?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554095,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced the commencement of the Phase Ia portion of a global clinical trial evaluating HMPL-A830 for the treatment of unresectable advanced or metastatic solid tumors.The first...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK1191","BK1587","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670332402","title":"Hutchmed Initiates Global Trial of Kras-Egfr-Antibody Conjugate Therapy Hmpl-A830 in Patients with Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670332402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670332402?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:00","pubTimestamp":1790553600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA8DPL31:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1191","00013","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402566","title":"HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402566","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402566?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:00","pubTimestamp":1790553600,"startTime":"0","endTime":"0","summary":"First-in-class KRAS-payload leveraging synchronized EGFR inhibitionHONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept.  27, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Compa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369472/0/en/hutchmed-initiates-global-trial-of-kras-egfr-antibody-conjugate-therapy-hmpl-a830-in-patients-with-solid-tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","BK1191","00013","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":121,"code":"91000000","status":"200"}]}}